TO

TORII PHARMACEUTICAL CO., LTD.

4551 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目4番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Torii Pharmaceutical Co., Ltd. is a prominent Japanese pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative healthcare solutions. Established with a commitment to improving patient lives, Torii focuses on a diverse range of therapeutic areas, including oncology, immunology, and infectious diseases. The company prides itself on its strong research and development capabilities, striving to bring new treatments to market that meet the evolving needs of healthcare providers and patients. With a vision to enhance global health, Torii collaborates with various partners in the pharmaceutical industry, fostering innovation and ensuring the highest standards of quality in its products.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TORII PHARMACEUTICAL CO., LTD.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-10 08:30
Regulatory News Service
臨時報告書
Japanese 215.5 KB
2025-06-19 02:04
Regulatory News Service
臨時報告書
Japanese 23.2 KB
2025-06-04 09:05
Regulatory News Service
訂正意見表明報告書
Japanese 171.8 KB
2025-05-08 08:56
Regulatory News Service
意見表明報告書
Japanese 373.9 KB
2025-03-31 08:30
Regulatory News Service
臨時報告書
Japanese 24.8 KB
2025-03-27 07:23
Regulatory News Service
内部統制報告書-第133期(2024/01/01-2024/12/31)
Japanese 24.0 KB
2025-03-27 07:22
Regulatory News Service
確認書
Japanese 9.3 KB
2025-03-27 07:18
Annual Report
有価証券報告書-第133期(2024/01/01-2024/12/31)
Japanese 1.0 MB
2024-08-01 03:06
Regulatory News Service
確認書
Japanese 9.2 KB
2024-08-01 03:05
Interim Report
半期報告書-第133期(2024/01/01-2024/12/31)
Japanese 187.0 KB
2024-04-26 08:07
Regulatory News Service
確認書
Japanese 9.2 KB
2024-04-26 08:06
Quarterly Report
四半期報告書-第133期第1四半期(2024/01/01-2024/03/31)
Japanese 143.5 KB
2024-03-29 07:17
Regulatory News Service
臨時報告書
Japanese 39.3 KB
2024-03-27 07:11
Regulatory News Service
内部統制報告書-第132期(2023/01/01-2023/12/31)
Japanese 24.0 KB
2024-03-27 07:10
Regulatory News Service
確認書
Japanese 9.3 KB

Automate Your Workflow. Get a real-time feed of all TORII PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TORII PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Basilea Pharmaceutica AG Logo
Develops and commercializes anti-infective drugs for severe bacterial and fungal infections.
Switzerland BSLN
Bavarian Nordic Logo
A biotech firm developing and manufacturing life-saving vaccines for travel and public health.
Denmark BAVA
Bayer AG Logo
A life science company in healthcare and agriculture, offering pharmaceuticals, self-care, and crop tech.
Germany BAY
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
Bioceltix S.A. Logo
Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.
Poland BCX
Biofarm S.A. Logo
Romanian pharma firm producing OTCs & therapeutic solutions for domestic & export markets.
Romania BIO
Biofrontera AG Logo
Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.
Germany B8F
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden BIOG
Bio-Gate AG Logo
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
Germany BIG1
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden BINV